Gamma-cyclodextrin as molecular chaperone in protein delivery and stabilization
The interaction of a small, monomeric cytoplasmic protein, Cellular retinoic acid binding protein I (CRABPI), with cyclodextrins (α-, β-, and
A forum for researchers, students and applicants in the field of cyclodextrin technology
The interaction of a small, monomeric cytoplasmic protein, Cellular retinoic acid binding protein I (CRABPI), with cyclodextrins (α-, β-, and
Materials are needed to increase the stability and half-life of therapeutic proteins during delivery. These materials should be biocompatible and
Cyclolab Ltd filed a patent application (US20220282001) on cyclodextrin containing physical mixtures and inclusion complexes that show improved protein stabilizing
The purpose of enzyme therapies (ERT) is simple: patients who suffer from enzyme deficiency should be treated by administering enzymes
Cytokines are key components of the immune system and play pivotal roles in anticancer immune response. Cytokines as either therapeutic
Protein-based pharmaceutical products are subject to a variety of environmental stressors, during both production and shelf-life. In order to preserve
Several cyclodextrins have been claimed by dozens of papers including huge works of Serno [1] and Hartl [2] to be